Wenjun Mou
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Oncology top 10%
- Cancer Cells and Metastasis 3
-
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 6
- Immunodeficiency and Autoimmune Disorders 4
-
- Diabetes and associated disorders 3
-
- Hematopoietic Stem Cell Transplantation 3
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Wenjun Mou
36 papers receiving 720 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 179
- Oncology 239
- Immunology 175
- Molecular Biology 393
- Pulmonary and Respiratory Medicine 102
Countries citing papers authored by Wenjun Mou
This map shows the geographic impact of Wenjun Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Mou more than expected).
Fields of papers citing papers by Wenjun Mou
This network shows the impact of papers produced by Wenjun Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Mou. The network helps show where Wenjun Mou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjun Mou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 14 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 20 | |
| 13 | 2017 | 31 | |
| 14 | 2017 | 11 | |
| 15 | 2016 | 8 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 3 | |
| 18 | 2014 | 55 | |
| 19 | 2013 | 80 | |
| 20 | 2011 | 159 |
About Wenjun Mou
Wenjun Mou is a scholar working on Immunology, Cancer Research, Hematology, Transplantation and Oncology, having authored 39 papers that have together received 731 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers), MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers), Diabetes and associated disorders (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (179 citations), Oncology (239 citations), Immunology (175 citations), Molecular Biology (393 citations) and Pulmonary and Respiratory Medicine (102 citations). Wenjun Mou has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Dan Lv, Yingxi Xu, Na Li, Lina Wang, Ralph A. Reisfeld, Rong Xiang, Yanhua Liu, Jingang Gui, Yu Xu and Chenghu Liu. Their work appears in journals such as Frontiers in Immunology, Clinical Immunology, Immunogenetics, BMC Immunology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.